消化指南

订阅

MedSci主页 / 所有栏目 / 消化指南

2020 ESPGHAN意见书：儿童患者维生素和微量元素状态的评估和解释

2020-06-01 欧洲儿科胃肠病学、肝病学和营养协会 J Pediatr Gastroenterol Nutr . 2020 Jun;70(6):873-881.

维生素

2020年6月，欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)发布了儿童患者维生素和微量元素状态的评估和解释的意见书。评估儿童患者维生素和微量元素的状态在儿童患者的临床管理中非常重要。本文主要介

中文标题：

2020 ESPGHAN意见书：儿童患者维生素和微量元素状态的评估和解释

英文标题：

Assessment and Interpretation of Vitamin and Trace Element Status in Sick Children: A Position Paper From the European Society for Paediatric Gastroenterology Hepatology, and Nutrition Committee on Nutrition

发布机构：

欧洲儿科胃肠病学、肝病学和营养协会

发布日期：

2020-06-01

简要介绍：

2020年6月，欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)发布了儿童患者维生素和微量元素状态的评估和解释的意见书。评估儿童患者维生素和微量元素的状态在儿童患者的临床管理中非常重要。本文主要介绍了各种临床评估方法，并讨论了相关的结果的解释。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESPGHAN意见书：儿童患者维生素和微量元素状态的评估和解释.pdf)] GetToolGuiderByIdResponse(projectId=1, id=ea7851c001916512, title=2020 ESPGHAN意见书：儿童患者维生素和微量元素状态的评估和解释, enTitle=Assessment and Interpretation of Vitamin and Trace Element Status in Sick Children: A Position Paper From the European Society for Paediatric Gastroenterology Hepatology, and Nutrition Committee on Nutrition, guiderFrom=J Pediatr Gastroenterol Nutr . 2020 Jun;70(6):873-881., authorId=0, author=, summary=2020年6月，欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)发布了儿童患者维生素和微量元素状态的评估和解释的意见书。评估儿童患者维生素和微量元素的状态在儿童患者的临床管理中非常重要。本文主要介, cover=https://img.medsci.cn/2020610/1591803371782_2020535.jpg, journalId=0, articlesId=null, associationId=515, associationName=欧洲儿科胃肠病学、肝病学和营养协会, associationIntro=欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN）是一个专业和科学的为任何我们服务的患者和他们的家庭寻找护理标准的协会。, copyright=0, guiderPublishedTime=Mon Jun 01 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年6月，欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN)发布了儿童患者维生素和微量元素状态的评估和解释的意见书。评估儿童患者维生素和微量元素的状态在儿童患者的临床管理中非常重要。本文主要介绍了各种临床评估方法，并讨论了相关的结果的解释。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1313, tagName=维生素)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=18, categoryName=儿科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1313, guiderKeyword=维生素, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4272, appHits=272, showAppHits=0, pcHits=709, showPcHits=3999, likes=0, shares=23, comments=8, approvalStatus=1, publishedTime=Wed Jun 10 23:57:00 CST 2020, publishedTimeString=2020-06-01, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Wed Jun 10 23:36:17 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Mon Jan 01 23:14:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESPGHAN意见书：儿童患者维生素和微量元素状态的评估和解释.pdf)])
2020 ESPGHAN意见书：儿童患者维生素和微量元素状态的评估和解释.pdf
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1194038, encodeId=bb811194038c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:56:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194035, encodeId=e5e311940357c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:55:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814699, encodeId=bf7581469980, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0775413889, createdName=ms5000001636872468, createdTime=Fri Aug 28 12:04:14 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809147, encodeId=3bae80914ef5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/bf55cfcb09b74a0cbf751a980fe04576/e4480eaa47ab42da91303dd1c72e723e.jpg, createdBy=89fd5188713, createdName=莉莉安 Lillian C., createdTime=Sat Aug 15 12:36:32 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808920, encodeId=6d1e80892047, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b9b5410942, createdName=ms6000001989772359, createdTime=Fri Aug 14 16:11:28 CST 2020, time=2020-08-14, status=1, ipAttribution=)]
    2022-02-16 14759b7dm93(暂无昵称)

    好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1194038, encodeId=bb811194038c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:56:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194035, encodeId=e5e311940357c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:55:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814699, encodeId=bf7581469980, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0775413889, createdName=ms5000001636872468, createdTime=Fri Aug 28 12:04:14 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809147, encodeId=3bae80914ef5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/bf55cfcb09b74a0cbf751a980fe04576/e4480eaa47ab42da91303dd1c72e723e.jpg, createdBy=89fd5188713, createdName=莉莉安 Lillian C., createdTime=Sat Aug 15 12:36:32 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808920, encodeId=6d1e80892047, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b9b5410942, createdName=ms6000001989772359, createdTime=Fri Aug 14 16:11:28 CST 2020, time=2020-08-14, status=1, ipAttribution=)]
    2022-02-16 14759b7dm93(暂无昵称)

    好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1194038, encodeId=bb811194038c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:56:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194035, encodeId=e5e311940357c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:55:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814699, encodeId=bf7581469980, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0775413889, createdName=ms5000001636872468, createdTime=Fri Aug 28 12:04:14 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809147, encodeId=3bae80914ef5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/bf55cfcb09b74a0cbf751a980fe04576/e4480eaa47ab42da91303dd1c72e723e.jpg, createdBy=89fd5188713, createdName=莉莉安 Lillian C., createdTime=Sat Aug 15 12:36:32 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808920, encodeId=6d1e80892047, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b9b5410942, createdName=ms6000001989772359, createdTime=Fri Aug 14 16:11:28 CST 2020, time=2020-08-14, status=1, ipAttribution=)]
    2020-08-28 ms5000001636872468

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1194038, encodeId=bb811194038c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:56:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194035, encodeId=e5e311940357c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:55:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814699, encodeId=bf7581469980, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0775413889, createdName=ms5000001636872468, createdTime=Fri Aug 28 12:04:14 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809147, encodeId=3bae80914ef5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/bf55cfcb09b74a0cbf751a980fe04576/e4480eaa47ab42da91303dd1c72e723e.jpg, createdBy=89fd5188713, createdName=莉莉安 Lillian C., createdTime=Sat Aug 15 12:36:32 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808920, encodeId=6d1e80892047, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b9b5410942, createdName=ms6000001989772359, createdTime=Fri Aug 14 16:11:28 CST 2020, time=2020-08-14, status=1, ipAttribution=)]
    2020-08-15 莉莉安 Lillian C.

    好

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1194038, encodeId=bb811194038c2, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:56:09 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194035, encodeId=e5e311940357c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d65e5209908, createdName=14759b7dm93(暂无昵称), createdTime=Wed Feb 16 14:55:28 CST 2022, time=2022-02-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=814699, encodeId=bf7581469980, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=90, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d0775413889, createdName=ms5000001636872468, createdTime=Fri Aug 28 12:04:14 CST 2020, time=2020-08-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=809147, encodeId=3bae80914ef5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=108, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200803/bf55cfcb09b74a0cbf751a980fe04576/e4480eaa47ab42da91303dd1c72e723e.jpg, createdBy=89fd5188713, createdName=莉莉安 Lillian C., createdTime=Sat Aug 15 12:36:32 CST 2020, time=2020-08-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=808920, encodeId=6d1e80892047, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b9b5410942, createdName=ms6000001989772359, createdTime=Fri Aug 14 16:11:28 CST 2020, time=2020-08-14, status=1, ipAttribution=)]
    2020-08-14 ms6000001989772359

    学习

    0

相关指南

2018 AACE/ACE立场声明：骨骼健康中应用维生素和矿物质

美国临床内分泌医师学会(AACE,American Association of Clinical Endocrinologists) · 2018-07-23

维生素矿物质补充剂在疾病防治中的临床应用：专家共识&mdash;烟酸

中华医学会(CMA,Chinese Medical Association) · 2014-12-20

维生素矿物质补充剂在疾病防治中的临床应用：专家共识一维生素B6

中华医学会(CMA,Chinese Medical Association) · 2014-10-20

维生素D与成年人骨骼健康应用指南（2014年标准版）

中国老年学学会骨质疏松委员会(OCCGS,Osteoporosis Committee of China Gerontological Society) · 2014-09-20

维生素矿物质补充剂在疾病防治中的临床应用：专家共识-维生素B2

中华医学会(CMA,Chinese Medical Association) · 2014-08-20

2014 BCSH维生素B12和叶酸障碍的诊断和治疗指南

英国血液学标准委员会(BCSH,British Committee for Standards in Haematology) · 2014-07-18

拓展阅读

2011 ENDO维生素D缺乏症的评估、治疗和预防

美国内分泌学会(TES,The Endocrine Society) · 2011-06-06

2011EMAS 立场声明：维生素D和绝经后的健康

欧洲女性与男性更年期协会(EMAS,European Menopause and Andropause Society) · 2011-11-17

维生素矿物质补充剂在肿瘤防治中的临床应用：专家共识

中华医学会(CMA,Chinese Medical Association) · 2013-02-01

2013 ESCEO推荐建议：老年或绝经妇女补充维生素D（更新版）

欧洲骨质疏松和骨关节炎临床经济学会(ESCEO,The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis) · 2013-02-07

2013USPSTF 成年人补充维生素D和钙补充剂防止骨折推荐声明

美国预防医学工作组(USPSTF,U.S. Preventive Services Task Force) · 2013-02-26

维生素矿物质补充剂在防治超重和肥胖中的临床应用：专家共识

中华医学会(CMA,Chinese Medical Association) · 2013-04-01